.Ascendis Pharma has emerged as a prospective hazard to BioMarin's Voxzogo, reporting period 3 growt...
.Though Alkeus Pharmaceuticals' dental eye illness possession neglected to considerably minimize geo...
.Along with a triad of biotechs striking the Nasdaq on Friday, it was actually simple to miss out on...
.Immune gate inhibitors are actually the superheroes of cancer treatment. Medications like Bristol M...
.Invite to this week's Chutes & Ladders, our summary of significant management hirings, shootings...
.Regeneron is back with long-lasting follow-up for its own LAG-3 inhibitor and also PD-1 prevention ...
.AstraZeneca has actually shared a very early examine the functionality of its internal antibody-dru...
.After revealing a period 3 launch based on favorable midstage outcomes, iTeos as well as GSK are fi...
.The FDA must be extra available and also collective to unleash a surge in commendations of rare con...
.It's an abnormally active Friday for biotech IPOs, with Zenas BioPharma, MBX and Bicara Therapies a...